Abstract:Background: Previous studies have shown that glycosylation of proteins ofen plays an important role in HCC. However, the potential mechanism of glycosylation in HCC has not been described systematically.Methods: We comprehensively evaluated the glycosylation patterns in HCC samples based on 43 glycosylation regulators, and annotated the modification patterns with the enrichment of immune cells and stromal cells. Considering the heterogeneity of HCC patients, the glycosylation score was constructed using single-sample gene set enrichment analysis (ssGSEA). We also explored the drugs that different HCC patients were sensitive to based on glycosylation mode and score.Results: We identified three glycosylation-regulated gene subtypes. By annotating the subtypes, it was found that the glycosylation regulated gene subtypes was highly matched with three immunophenotypes of HCC (immune-inflamed, immune-excluded, and immune-desert), regardless of the characteristics of immune cell infiltration or prognosis. Based on the characteristic genes of glycosylation-regulated gene subtypes, we constructed a glycosylation-related model, and found that glycosylation-related model was highly consistent with the glycosylation regulated gene subtypes. The glycosylation score that evaluates the glycosylation characteristics of a single HCC sample has high prognostic value, and the prognosis of patients with high glycosylation score is significantly worse. Interestingly, we found that the glycosylation score was closely related to tumor node metastasis (TNM) staging. By applying glycosylation-regulated gene subtypes and glycosylation score to explore the sensitivity of different patients to anticancer drugs, it was found that the sensitivity of Thapsigargin, Shikonin, Embelin and Epothilone. B was closely related to the glycosylation mode.Conclusion: This study reveals that the diversity of glycosylation patterns plays an important role in HCC. Therefore, evaluating the glycosylation patterns of patients with HCC will be helpful in identifying the characteristics of immune cell infiltration and selecting accurate treatment methods.

Insights on N-glycosylation of human haptoglobin and its association with cancers.

Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases

Protein Expression and Fucosylated Glycans of the Serum Haptoglobin-Beta Subunit in Hepatitis B Virus-Based Liver Diseases

Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma

N-linked glycan changes of serum haptoglobin β chain in liver disease patients.

Disease-Specific Haptoglobin N-Glycosylation in Inflammatory Disorders between Cancers and Benign Diseases of 3 Types of Female Internal Genital Organs

Glycosylation of serum haptoglobin as a marker of gastric cancer: an overview for clinicians

Glycoproteomics investigation of human hepatocellular carcinoma cell lines

Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications

Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.

Identification of N-glycosylation in Hepatocellular Carcinoma Patients' Serum with a Comparative Proteomic Approach.

N-Linked Glycan Changes Of Serum Haptoglobin Beta Chain In Liver Disease Patients

Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications

N-glycan, a biomarker in current cancer diagnosis

Progress of Proteomics Driven Precision Medicine-From a Glycosylation View.

Characterization of Glycosylation Regulator-Mediated Glycosylation Modification Patterns and Tumor Microenvironment Infiltration in Hepatocellular Carcinoma

Altered glycosylation in cancer: molecular functions and therapeutic potential

N-glycan Profiles As Tools in Diagnosis of Hepatocellular Carcinoma and Prediction of Healthy Human Ageing

Integrated plasma proteomics and N‐glycoproteomics reveals alterations in the N‐glycosylation in Chinese hepatocellular carcinoma patients

Investigation on Glycosylation Patterns of Proteins from Human Liver Cancer Cell Lines Based on the Multiplexed Proteomics Technology

Causal link between immunoglobulin G glycosylation and cancer: A potential glycobiomarker for early tumor detection